Should I buy Procter & Gamble stock in 2025?

Why trust HelloSafe?

At HelloSafe, our expert has been monitoring the performance of Procter & Gamble for over three years. Each month, more than a million users in the United States rely on our insights to understand market trends and discover the best investment opportunities. Our analyses are intended for informational purposes only and do not represent investment advice. In line with our ethical guidelines, we have never been, and will never be, compensated by Procter & Gamble.

What is Procter & Gamble?

How much is Procter & Gamble stock?

The price of Procter & Gamble stock is declining this week. PG shares are currently trading at $159.98, down 1.59% (-$2.59) over the past 24 hours and -0.65% for the week. The company’s market capitalization stands at $375.08 billion, with an average three-month daily volume of 8.52 million shares. Procter & Gamble’s P/E ratio is 25.41, offering a dividend yield of 2.64%, and the stock has a low beta of 0.42, signaling below-market volatility. With its strong dividend track record and defensive sector position, P&G may appeal to risk-averse investors, even as short-term headwinds affect performance.

Our full analysis on Procter & Gamble stock

After reviewing Procter & Gamble’s latest quarterly earnings, chart performance over the past three years, and integrating a diverse range of analyses through our proprietary algorithms, it’s clear this consumer staples giant is at a pivotal point. By juxtaposing key financial metrics, technical signals, sectoral trends, and competitor benchmarking, we find that Procter & Gamble’s (PG) current valuation reflects both defensive resilience and pockets of opportunity. So, why might Procter & Gamble stock once again become a strategic entry point into the consumer staples sector as we look ahead to 2025?

Recent Performance and Market Context

Procter & Gamble’s stock price has shown notable stability, trading at $159.98 as of May 2, 2025, with a market capitalization of $375 billion. Over the past twelve months, the stock has delivered a comparatively modest decline of -2.09%, outperforming many discretionary peers as global markets digested persistent macroeconomic uncertainties. The six-month performance, down 3.10%, also reflects defensive sector characteristics, with volatility muted—PG’s beta is just 0.42, reinforcing its positioning as a low-volatility anchor for diversified portfolios.

Recent company events include the announcement of the 69th consecutive annual dividend increase, underscoring both the strength of P&G’s cash flows and management’s commitment to shareholder returns. Even amid a challenging consumer demand landscape—driven by cautious sentiment and geopolitical uncertainty—PG’s 1% organic sales growth in Q3 FY2025 and a 1% increase in EPS signal underlying operational resilience.

Within the macro environment, the consumer staples sector remains broadly favored given its defensive nature in periods of consumer uncertainty and inflation. As consumers gravitate toward trusted, essentials-oriented brands, P&G’s dominant reputation acts as a robust backstop for long-term investors.

Technical Analysis

Examining technical signals, Procter & Gamble currently trades in a well-defined consolidation range of $160–$180, with the present price testing support at $159.05 (recent daily low) and the 52-week low at $156.58. Although short-term moving averages (20, 50, 100, and 200 days) form a resistance cluster at $166–$167, these levels are not far above the current quote, suggesting any directional breakout could quickly regain momentum.

• RSI (14 days): At 45.94, the RSI is neutral, highlighting that the stock is neither overbought nor oversold.
• MACD (12,26,9): The MACD presents a mild buy signal (-1.19), indicating the potential for an upward inflection should bullish catalysts materialize.
• Moving Averages: Near-term prices below key moving averages typically call for caution, but with the stock probing strong long-term support, imminent downward risk appears limited.

PG’s significant trading volume and the resistance block near $167–$169 suggest that a positive earnings surprise, or even constructive sector momentum, could propel shares decisively higher. This technical structure sets the stage for dynamic movement, especially for investors tracking inflection points around established support.

Fundamental Analysis

Despite recent top-line softness—with Q3 FY2025 revenue at $19.78 billion, down 2% year-over-year—Procter & Gamble’s ability to grow EPS by 1% and maintain robust profitability speaks to deep-rooted operational efficiency. Notably:

• Valuation: PG’s trailing P/E sits at 25.41, with a forward P/E of 23.19, signaling a valuation premium justified by quality, capital efficiency, and defensive attributes. Compared to the S&P 500 consumer staples average, this premium is consistent with the company’s superior brand strength and dividend record.
• Dividend Yield: At 2.64%—above its 5-year average—PG continues to deliver reliable income, a major draw for income-seeking investors and a buffer in volatile markets.
• Strategic Moat: With over 65 category-defining brands and unrivaled distribution, P&G commands an enviable global footprint. Its focus on innovation across price segments, disciplined capital allocation, and relentless productivity improvements enhance both competitive positioning and margin durability.
• Growth Prospects: Premiumization and innovation remain at the core of management’s strategy. Organic sales growth and robust capex discipline support sustainable, margin-accretive expansion even as input costs and tariffs present headwinds.

Volume and Liquidity

PG’s average daily traded volume of 8.52 million shares confers deep liquidity, supporting efficient price discovery and reducing transaction costs for investors. The entire 2.34 billion shares outstanding are available as free float, enabling large institutional participants to adjust positions without impacting price stability. Consistently high volume reflects enduring market confidence, even as the stock navigates consolidation between major technical levels.

Such liquidity and institutional involvement—the Vanguard Group remains a lead shareholder—are hallmarks of a core blue-chip holding, distinctly appealing for both tactical traders and long-term institutional investors.

Catalysts and Positive Outlook

Multiple organic and external catalysts could favorably alter Procter & Gamble’s growth trajectory in the coming year:

• Innovation Pipeline: The portfolio’s premium innovation and expanded offerings across emerging and developed markets support both margin enhancement and volume stabilization.
• Cost and Productivity Gains: Management’s operational rigor, particularly in supply chain optimization and asset utilization, is expected to drive incremental margin improvements and support future EPS growth.
• ESG Leadership: As consumers and institutions increasingly favor sustainable practices, P&G’s investments in ESG initiatives place it among global leaders for responsible business.
• Potential Price Actions: Forthcoming tariff-induced price adjustments, if well-executed, can mitigate margin pressure and reinforce brand premiumization, provided that price elasticity is managed prudently.
• Dividend Aristocracy: P&G's peerless 69-year dividend growth streak, alongside expectations of further increases, will keep the stock in focus for income funds and conservative mandates.

Cumulatively, these levers could support consensus projections for FY2025 core EPS growth of 2–4%, with analysts targeting a price of $180.83 (+13.03% implied upside from current levels).

Investment Strategies

Given PG’s technical and fundamental backdrop, several entry points and positioning strategies warrant attention:

• Short-term: The stock’s proximity to multi-month support ($159–$160) presents an appealing risk/reward, especially as it has historically rebounded from these levels during previous macro slowdowns. A positive technical reversal or catalyst could initiate a swift run toward the upper end of the trading band.
• Medium-term: Should macro conditions stabilize and consumer confidence return, P&G's earnings consistency and dividend growth could propel a gradual rerating, with resistance around $167–$169 offering the next meaningful price target.
• Long-term: For investors building diversified, low-volatility portfolios, P&G’s brand leadership, commitment to margin-preserving innovation, and proven capital return discipline remain highly compelling. Current valuation levels, above-average dividend yield, and robust free cash flow suggest that long-term compounding potential is intact—particularly when considering past resilience during downturns.

Those seeking ideal positioning may look to accumulate at the lower end of the established range, particularly as the stock consolidates against major support, or ahead of potential catalysts such as earnings upgrades, dividend announcements, or sector rotation in favor of defensives.

Is it the Right Time to Buy Procter & Gamble?

P&G stands at a confluence of technical support, attractive relative valuation, and unmatched sector fundamentals. The company’s peerless dividend growth, powerful pricing and innovation levers, and brand equity form a robust shield in turbulent markets—and, crucially, prime it for recovery as macro headwinds ease.

While near-term revenue growth may face hurdles, P&G’s unique combination of operational discipline, commitment to capital return, and strategic agility point to a constructive outlook. The current price near key support, below long-term averages, could represent an excellent entry for investors seeking a blend of stability, yield, and potential appreciation—especially with consensus targets indicating substantial upside.

In summary, Procter & Gamble’s stock may be entering a new bullish phase, fueled by both defensive demand and strategic execution. As investors continue to prioritize quality and yield in uncertain times, P&G once again proves itself as a cornerstone of consumer staples—and a stock that merits renewed, serious consideration at these levels. With its impressive track record and forward-driven momentum, Procter & Gamble offers an outstanding opportunity for those seeking both resilience and upside in today’s dynamic market environment.

How to buy Procter & Gamble stock in United States?

Buying Procter & Gamble (PG) stock online is straightforward and secure when you use a regulated broker in the United States. There are two main approaches: you can purchase PG shares for cash (spot buying) to become a direct shareholder, or trade PG through Contracts for Difference (CFDs), a derivative product well-suited for more active traders. Each method has its own features, fees, and risk profile. To help you find the best platform for your needs, we provide a detailed broker comparison further down this page.

Spot Buying

A cash purchase, or spot buying, means you’re acquiring real Procter & Gamble shares listed on the New York Stock Exchange. As a shareholder, you benefit from potential share price gains and receive dividends as declared by the company. Most U.S. brokers charge a fixed commission per trade—typically around $5 per transaction.

Example

Suppose the Procter & Gamble (PG) share price is $159.98. With a $1,000 investment, you can buy approximately 6 shares, accounting for a $5 broker commission ([$1,000 - $5] / $159.98 ≈ 6.23 shares; you can buy 6 whole shares).

✔️ Gain scenario

If PG's share price rises by 10%, your 6 shares are now worth $1,055.88, up from $959.88 (excluding your $5 commission).
Result: +$96 gross gain, or +10% on your $1,000 investment (before taxes and other fees).

Trading via CFD

CFDs (Contracts for Difference) are financial instruments that allow you to speculate on Procter & Gamble's share price without owning the underlying stock. CFD trading enables you to use leverage—meaning a small deposit can control a larger position—but it involves greater risk. Instead of a fixed commission, brokers typically charge a spread (the difference between buy and sell prices) and overnight financing fees if you hold your position for more than a day.

Example

You open a CFD position on Procter & Gamble shares with $1,000 and use 5x leverage. This gives you $5,000 in market exposure.

✔️ Gain scenario

If PG’s stock rises by 8%, your position grows by 8% × 5 = 40%.
Result: Your gain would be +$400 on your $1,000 investment (not including spreads and overnight fees).

Final Advice

Before committing funds, always compare brokers’ fees, service levels, and account conditions, as these can significantly impact your returns. Whether you choose to invest for the long term with real shares or seek short-term gains through CFDs depends on your objectives, risk profile, and experience. Explore our broker comparison section below to choose the platform that’s right for your investment journey.

Application

Rates & Fees

Learn More

#1

30+ million users

#1Recommended by Forbes

eToro

Rates & Fees

4.9

Discover

51% of CFD accounts lose money. You will never lose more than your investment.

#2

CFD and Indices Expert

#2

IG

Rates & Fees

4.9

Discover

74% of CFD accounts lose money. Your capital is at risk.

#3

CFD specialist

#3

Avatrade

Rates & Fees

4.8

On the broker's website

Our 7 tips for buying Procter & Gamble stock

The latest news about Procter & Gamble

Procter & Gamble reported earnings per share of $1.54 for Q3 FY2025, narrowly beating analyst expectations. Despite a slight 2% decline in revenue to $19.78 billion, the company managed to outperform consensus EPS estimates by delivering 1% year-over-year earnings growth. This resilience, achieved against a backdrop of softening consumer demand and a 1% volume decrease, underscores Procter & Gamble’s ability to defend its margins and maintain shareholder returns even as sales fluctuate. The positive earnings performance was particularly notable given the challenging macroeconomic environment in the U.S. market, reaffirming P&G’s reputation as a defensive stalwart in times of economic uncertainty.

Procter & Gamble’s dividend aristocrat credentials remain unmatched, with a 69th consecutive annual dividend increase recently confirmed. The company’s board authorized an annual dividend of $4.23 per share for 2025, reinforcing its strong commitment to shareholder distributions. P&G has now delivered 135 consecutive years of dividend payments, anchoring its status as one of the most consistent income generators among large-cap U.S. equities. This unparalleled track record is highly attractive to U.S. investors seeking stability and reliable cash flow, especially in the current environment of market volatility and muted growth expectations.

Management reaffirmed commitment to innovation with targeted capital expenditures and focus on premium product mix for U.S. consumers. For fiscal 2025, P&G plans to allocate 4–5% of net sales to capital spending in the U.S., emphasizing investments in superior innovation across diverse price tiers. Recent quarters have shown favorable trends from premium product launches, particularly in the grooming and health care segments, which posted organic sales growth of 3% and 4% respectively. These initiatives are strategically aimed at driving domestic market share and improving category leadership, further solidifying P&G’s competitive advantage in the U.S. household and personal care arena.

Technical indicators reveal a neutral-to-cautiously-positive stance, with the MACD flashing a buy signal and analyst consensus suggesting upside. While Procter & Gamble’s share price is currently trading below key moving averages, the short-term MACD momentum indicator has turned positive. The 14-day RSI is neutral at 45.94, suggesting the stock is neither overbought nor oversold, and may be poised for stabilizing price action. Notably, consensus analyst price targets stand at $180.83—a roughly 13% premium to current levels—a constructive outlook that reflects Wall Street’s continued confidence in P&G’s operational resilience and long-term fundamentals.

The company’s defensive sector positioning and robust U.S. presence provide stability amidst broader economic uncertainty. Procter & Gamble’s leadership in consumer staples is particularly valued by U.S.-based investors during periods of economic instability, as essential products tend to enjoy steady demand. With approximately 108,000 employees nationwide and iconic brands entrenched in the daily lives of American consumers, P&G remains well-insulated from cyclical downturns. Ongoing productivity enhancements and cost management are bolstering its fixed asset efficiency, further protecting profitability even as management tempers growth expectations in response to softer retail traffic and macro headwinds.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.